Jane Street’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,800
Closed -$745K 11739
2025
Q3
$745K Hold
40,800
﹤0.01% 6952
2025
Q2
$820K Buy
+40,800
New +$785K ﹤0.01% 5994
2022
Q3
Sell
-16,100
Closed -$238K 10047
2022
Q2
$238K Buy
16,100
+2,700
+20% +$44.2K ﹤0.01% 7946
2022
Q1
$259K Buy
13,400
+2,000
+18% +$35.7K ﹤0.01% 8616
2021
Q4
$197K Sell
11,400
-4,700
-29% -$80.1K ﹤0.01% 8831
2021
Q3
$269K Buy
+16,100
New +$241K ﹤0.01% 8391
2021
Q2
Sell
-18,300
Closed -$219K 10077
2021
Q1
$219K Buy
+18,300
New +$221K ﹤0.01% 8140

Other funds holding INVA

Jane Street's INVA Position: Q1 2026 in Review

Jane Street sold out of Innoviva (INVA) in Q1 2026, closing a stake of 26,572 shares — an estimated $531K sold.

Jane Street first reported a position in INVA in Q2 2013 and held it in 32 quarters. The position peaked at $8.9M in Q2 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Jane Street reported no remaining Innoviva position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 26,572 Innoviva shares in Q1 2026, an estimated $531K.
  • Jane Street first reported a position in Innoviva in Q2 2013 and held it in 32 quarters.
  • Jane Street's Innoviva position peaked at $8.9M in Q2 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.